Harrow, Inc. (HROW) Deep Dive Video

Summary

Harrow offers asymmetric upside if its branded ophthalmology platform scales fast enough to outrun gross-to-net volatility and a leveraged balance sheet.

View HROW stock page · Read the HROW research report

Loading the video player…